Clinical Trial

A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study evaluates the safety, tolerability, and pharmacokinetics (PK) of a single dose administration of VH4527079 by subcutaneous (SC) injection or by intravenous (IV) infusion in healthy adult participants and multiple dose administration by IV infusion in healthy adult participants and in Persons with HIV (PWH).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-10-18; most recent amendment 2026-06-29.
Status change: Recruiting → Active, Not Recruiting 2026-03-04
Status change: Active, Not Recruiting → Recruiting 2025-04-21
Status change: Recruiting → Active, Not Recruiting 2024-12-09
Trial Details
NCT Number NCT06652958
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 102 participants
Start Date 2024-10-02
Primary Completion 2026-09-09 (estimated)
Study Completion 2026-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-30